Literature DB >> 9657444

Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system.

H R Lijnen1, J Silence, G Lemmens, L Frederix, D Collen.   

Abstract

To investigate a potential physiological role of the plasminogen/plasmin system in activation of the matrix metalloproteinase (MMP) system, the distribution of latent and active MMP-2 (gelatinase A) or MMP-9 (gelatinase B) was monitored in aorta extracts and in serum-free conditioned cell culture medium obtained from wild-type (WT) mice and from mice with deficiency of tissue-type plasminogen activator (t-PA(-/-)), urokinase-type plasminogen activator (u-PA(-/-)), plasminogen activator inhibitor-1 (PAI-1(-/-)) or plasminogen (Plg(-/-)). In aorta extracts, the contribution of active MMP-2 to the total MMP-2 level ranged between 7 and 16% for the different genotypes, whereas active MMP-9 was not detected. The contribution of active 58 kDa MMP-2 to the total MMP-2 level (active plus latent) ranged between 14 and 29% (mean of 3 experiments) for fibroblasts of the different genotypes, and between 18 and 32% for smooth muscle cells, and was relatively constant in time (7-72 h). The contribution of active 83 kDa MMP-9 to the total MMP-9 level ranged between 15 and 29% for fibroblasts of the different genotypes and was relatively constant in time (24-72 h); corresponding values were 17 to 57% for smooth muscle cells, with the exception of Plg(-/-) smooth muscle cells which had undetectable levels of active MMP-9. Addition of plasmin(ogen) to the cell culture medium of fibroblasts did not significantly affect the distribution of active and latent MMP-2, but resulted in an approximately two-fold enhancement of the contribution of active MMP-9. In macrophages of Plg(-/-) mice, active MMP-9 was detected only when the cells were cultured in the presence of plasminogen. These data indicate that activation of proMMP-2 occurs independently of the physiological plasminogen activators and of plasmin(ogen) in all the cell types evaluated. Activation of proMMP-9 was enhanced in the presence of plasmin(ogen), but active MMP-9 was also detected in fibroblasts of Plg(-/-) mice, indicating that in vivo activation may occur via plasmin(ogen)-independent mechanisms.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9657444

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  16 in total

Review 1.  Proteases at the endometrial-trophoblast interface: their role in implantation.

Authors:  Lois A Salamonsen; Guiying Nie
Journal:  Rev Endocr Metab Disord       Date:  2002-05       Impact factor: 6.514

2.  Gαq G proteins modulate MMP-9 gelatinase during remodeling of the murine femoral artery.

Authors:  Yiping Zou; Yuyang Fu; Mark G Davies
Journal:  J Surg Res       Date:  2012-05-08       Impact factor: 2.192

3.  Proteolytic action of kallikrein-related peptidase 7 produces unique active matrix metalloproteinase-9 lacking the C-terminal hemopexin domains.

Authors:  Vishnu C Ramani; Gur P Kaushal; Randy S Haun
Journal:  Biochim Biophys Acta       Date:  2011-05-17

Review 4.  Role of mesenchymal stem cell-derived fibrinolytic factor in tissue regeneration and cancer progression.

Authors:  Beate Heissig; Douaa Dhahri; Salita Eiamboonsert; Yousef Salama; Hiroshi Shimazu; Shinya Munakata; Koichi Hattori
Journal:  Cell Mol Life Sci       Date:  2015-09-09       Impact factor: 9.261

5.  Urokinase-type plasminogen activator and its receptor synergize to promote pathogenic proteolysis.

Authors:  H M Zhou; A Nichols; P Meda; J D Vassalli
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

6.  In vivo perimenstrual activation of progelatinase B (proMMP-9) in the human endometrium and its dependence on stromelysin 1 (MMP-3) ex vivo.

Authors:  V Rigot; E Marbaix; P Lemoine; P J Courtoy; Y Eeckhout
Journal:  Biochem J       Date:  2001-08-15       Impact factor: 3.857

Review 7.  Matrix metalloproteinases in the progression of heart failure: potential therapeutic implications.

Authors:  Y Y Li; A M Feldman
Journal:  Drugs       Date:  2001       Impact factor: 9.546

8.  The plasmin system is induced by and degrades amyloid-beta aggregates.

Authors:  H M Tucker; M Kihiko; J N Caldwell; S Wright; T Kawarabayashi; D Price; D Walker; S Scheff; J P McGillis; R E Rydel; S Estus
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

9.  Polymorphism of SERPINE2 gene is associated with pulmonary emphysema in consecutive autopsy cases.

Authors:  Koichi Fujimoto; Shinobu Ikeda; Tomio Arai; Noriko Tanaka; Toshio Kumasaka; Takeo Ishii; Kozui Kida; Masaaki Muramatsu; Motoji Sawabe
Journal:  BMC Med Genet       Date:  2010-11-10       Impact factor: 2.103

10.  The plasminogen fibrinolytic pathway is required for hematopoietic regeneration.

Authors:  Beate Heissig; Leif R Lund; Haruyo Akiyama; Makiko Ohki; Yohei Morita; John Rømer; Hiromitsu Nakauchi; Ko Okumura; Hideoki Ogawa; Zena Werb; Keld Danø; Koichi Hattori
Journal:  Cell Stem Cell       Date:  2007-12-13       Impact factor: 24.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.